Notice Title

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Oxycodone Hydrochloride
Active Ingredient: Oxycodone hydrochloride 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: ORSPEC Pharma Management Limited
Manufacturer: Labomed Pharmaceutical Company S.A., Koropi, Greece
Note: This consent is valid for two years from the date of publication of this notice.


Dated this 16th day of December 2024.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on the 11th day of September 2013).